Microbix Biosystems Inc. T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs™) that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.

TSX:MBX - Post by User

Microbix Biosystems Inc.

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Jan 03, 2024 1:04pm

107 Views

Post# 35808987

Microbix Achieves Further QAPs Sales Record

MISSISSAUGA, Ontario, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces it has sold and shipped over one million Canadian Dollars (“C$ 1 Million”) of its quality assessment products (“QAPs™”) to a leading agency that provides clinical laboratory accreditation services. This is Microbix’s largest-ever individual shipment to a lab proficiency-testing (“PT”) and external quality assessment (“EQA”) services provider.

Microbix Achieves Further QAPs Sales Record (globenewswire.com)

<< Previous

Bullboard Posts

Next >>

These stocks are the top picks for Canadian ETFs